Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 11, 2007

Vanderbilt Selects Nexus Compound Management Technology

  • Vanderbilt University’s High-Throughput Screening (HTS) Facility has selected Nexus Biosystems’ Universal Store to manage its collection of synthetic small molecules and natural products. The Universal Store will serve as the main repository for maintaining and managing Vanderbilt’s collection as a part of its basic research and translational drug discovery activities. Multiple local and extramural medicinal, synthetic, and natural products-based chemistry efforts contribute to the population of this collection.

    The HTS facility utilizes instrumentation and data-management tools to interrogate chemical libraries, enabling identification of compounds and reagents for use in basic research, therapeutics, and diagnostics. In addition the facility exists as a national resource for screening GPCRs, ion channels, and transporters as one of the 10-member, NIH-funded, Molecular Libraries Screening Center Network.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »